Amgen Inc. buy Truist Financial Co.
Start price
29.11.23
/
50%
€243.40
Target price
29.11.24
€291.23
Performance (%)
22.18%
Price
04.10.24
€291.20
Summary
This prediction is currently active. The prediction currently has a performance of 22.18%. Dividends of €6.20 are taken into consideration when calculating the performance. This prediction currently runs until 29.11.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amgen Inc. | 0.761% | 0.761% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $320.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat